Showing results (821-830 of 846) with videos related to
Sort By:
Pageof 85
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patientsM Hecht, L Zimmer, C Loquai, et al.Plos One|July 7, 2012
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionStephane Champiat, Rui André Saraiva Raposo, Nicholas J Maness, et al.Plos Pathogens|January 8, 2016
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionGlen M Chew, Tsuyoshi Fujita, Gabriela M Webb, et al.Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.AIDS (London, England)|June 15, 2021
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteriaJesse Fajnzylber, Radwa Sharaf, John N Hutchinson, et al.Journal of Magnetic Resonance Imaging : JMRI|May 5, 2022
Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic CholangiocarcinomasAndrea S Kierans, Kyle J Lafata, Daniel R Ludwig, et al.Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.Abdominal Radiology (New York)|April 28, 2025
Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysisMarybeth Nedrud, Tanya Wolfson, Brian Allen, et al.Plos Pathogens|January 19, 2021
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ARTCharline Bacchus-Souffan, Mark Fitch, Jori Symons, et al.Journal of Virology|March 29, 2013
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaquesStéphane Champiat, Keith E Garrison, Rui André Saraiva Raposo, et al.Pageof 85